Vycor Medical Inc
VYCO· OTC
Released Nov 12, 2019
10-Q filed Nov 12, 2019, 43 days after period end · 0001493152-19-016811
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2019 | Q3 2018 | Q3 2017 | Q3 2016 |
|---|---|---|---|---|
| Revenue | $322.88K | $456.21K | $379.07K | $325.78K |
| Net Income | -$209.61K | -$152.18K | -$428.40K | -$331.90K |
| EPS Diluted | -$0.02 |
Vycor Medical Inc · CIK 1424768 · Engraved from SEC EDGAR
| -$0.01 |
| -$0.03 |
| -$0.04 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.